-
1
-
-
0035832261
-
Prevalence of diagnosed atrial fibrillation in adults: National implication for rhythm management and stroke prevention: The anticoagulation and Risk Factors in Atria Fibrillation (Atria) Study
-
Go AS, Hilek M, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implication for rhythm management and stroke prevention: the anticoagulation and Risk Factors in Atria Fibrillation (Atria) Study. JAMA 2001 285 : 2370 5.
-
(2001)
JAMA
, vol.285
, pp. 2370-5
-
-
Go, A.S.1
Hilek, M.2
Phillips, K.A.3
Chang, Y.4
Henault, L.E.5
Selby, J.V.6
Singer, D.E.7
-
2
-
-
33748156096
-
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - Executive summary
-
American College of Cardiology; American Heart AssociationEuropean Society of Cardiology
-
Fuster V, Rydèn LE, Cannom SD, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Zamorano JL, Smith SC Jr., Jacobs AK, Adams CD, Anderson JL, Antman EM, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B American College of Cardiology; American Heart Association European Society of Cardiology ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - executive summary Eur Heart J 2006 27 : 1979 2030.
-
(2006)
Eur Heart J
, vol.27
, pp. 1979-2030
-
-
Fuster, V.1
Rydèn, L.E.2
Cannom, S.D.3
Crijns, H.J.4
Curtis, A.B.5
Ellenbogen, K.A.6
Halperin, J.L.7
Le Heuzey, J.Y.8
Kay, G.N.9
Lowe, J.E.10
Olsson, S.B.11
Prystowsky, E.N.12
Tamargo, J.L.13
Wann, S.14
Priori, S.G.15
Blanc, J.J.16
Budaj, A.17
Camm, A.J.18
Dean, V.19
Deckers, J.W.20
Despres, C.21
Dickstein, K.22
Lekakis, J.23
McGregor, K.24
Metra, M.25
Morais, J.26
Osterspey, A.27
Zamorano, J.L.28
Smith Jr., S.C.29
Jacobs, A.K.30
Adams, C.D.31
Anderson, J.L.32
Antman, E.M.33
Hunt, S.A.34
Nishimura, R.35
Ornato, J.P.36
Page, R.L.37
Riegel, B.38
more..
-
3
-
-
0030855939
-
Incidence of and risk factors for atrial fibrillation in older adults
-
Ptsaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, Furberg CD, Rautaharju PM. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997 96 : 2455 61.
-
(1997)
Circulation
, vol.96
, pp. 2455-61
-
-
Ptsaty, B.M.1
Manolio, T.A.2
Kuller, L.H.3
Kronmal, R.A.4
Cushman, M.5
Fried, L.P.6
White, R.7
Furberg, C.D.8
Rautaharju, P.M.9
-
4
-
-
2542507510
-
Characterization of different subset of atrial fibrillation in general practice in France: The ALFA study
-
Levy S, Maarek M, Coumel P, Guize L, Lekieffre J, Medvedowsky JL, Sebaoun A. Characterization of different subset of atrial fibrillation in general practice in France: the ALFA study. Circulation 1999 99 : 3028 35.
-
(1999)
Circulation
, vol.99
, pp. 3028-35
-
-
Levy, S.1
Maarek, M.2
Coumel, P.3
Guize, L.4
Lekieffre, J.5
Medvedowsky, J.L.6
Sebaoun, A.7
-
5
-
-
0002848836
-
Tachycardia-induced tachycardia: A mechanism of initiation of atrial fibrillation
-
In: eds. Di Marco, J.P., Pristowsky, E.N. Armonk, NY: Futura
-
Pristowsky EN. Tachycardia-induced tachycardia: a mechanism of initiation of atrial fibrillation. In : Atrial Arrhythmias: State of Art, eds Di Marco JP, Pristowsky EN. Armonk, NY : Futura, 1995.
-
(1995)
Atrial Arrhythmias: State of Art
-
-
Pristowsky, E.N.1
-
6
-
-
9244247612
-
Obesity and the risk of new onset AF atrial fibrillation
-
Wang TJ, Parise H, Levy D, D'Agostino RB Sr., Wolf PA, Vasan RS, Benjamin EJ. Obesity and the risk of new onset AF atrial fibrillation. JAMA 2004 292 : 2471 7.
-
(2004)
JAMA
, vol.292
, pp. 2471-7
-
-
Wang, T.J.1
Parise, H.2
Levy, D.3
D'Agostino Sr., R.B.4
Wolf, P.A.5
Vasan, R.S.6
Benjamin, E.J.7
-
7
-
-
0028244264
-
Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials
-
Atrial Fibrillation Investigators.
-
Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994 154 : 1449 57.
-
(1994)
Arch Intern Med
, vol.154
, pp. 1449-57
-
-
-
8
-
-
0036797537
-
A population-based study of the long-term risk associated with atrial fibrillation: 20 year follow-up of the Renfrew/Paisley study
-
Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risk associated with atrial fibrillation: 20 year follow-up of the Renfrew/Paisley study. Am J Med 2002 113 : 359 64.
-
(2002)
Am J Med
, vol.113
, pp. 359-64
-
-
Stewart, S.1
Hart, C.L.2
Hole, D.J.3
McMurray, J.J.4
-
9
-
-
0029029056
-
The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba Follow-Up Study
-
Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 1995 98 : 476 84.
-
(1995)
Am J Med
, vol.98
, pp. 476-84
-
-
Krahn, A.D.1
Manfreda, J.2
Tate, R.B.3
Mathewson, F.A.4
Cuddy, T.E.5
-
10
-
-
0348047552
-
Cost of care distribution in atrial fibrillation patients: The COCAF study
-
Le Heuzey JY, Paziaud O, Piot O, Said MA, Copie X, Lavergne T, Guize L. Cost of care distribution in atrial fibrillation patients: the COCAF study. Am Heart J 2004 147 : 121 6.
-
(2004)
Am Heart J
, vol.147
, pp. 121-6
-
-
Le Heuzey, J.Y.1
Paziaud, O.2
Piot, O.3
Said, M.A.4
Copie, X.5
Lavergne, T.6
Guize, L.7
-
11
-
-
34447280098
-
Comparison of rate versus rhythm control for atrial fibrillation in patients with left ventricular dysfunction (from the AFFIRM Study)
-
Freudenberger RS, Wilson AC, Kostis JB. Comparison of rate versus rhythm control for atrial fibrillation in patients with left ventricular dysfunction (from the AFFIRM Study). Am J. Cardiol 2007 100 : 247 52.
-
(2007)
Am J. Cardiol
, vol.100
, pp. 247-52
-
-
Freudenberger, R.S.1
Wilson, A.C.2
Kostis, J.B.3
-
12
-
-
0034715973
-
Rhythm or rate control in atrial fibrillation - Pharmacologic Intervention in Atrial Fibrillation (PIAF): A randomized trial
-
Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation - Pharmacologic Intervention in Atrial Fibrillation (PIAF): a randomized trial. Lancet 2000 356 : 1789 94.
-
(2000)
Lancet
, vol.356
, pp. 1789-94
-
-
Hohnloser, S.H.1
Kuck, K.H.2
Lilienthal, J.3
-
13
-
-
0025675680
-
Remodelling of the rat right and left ventricles in experimental hypertension
-
Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT. Remodelling of the rat right and left ventricles in experimental hypertension. Circ Res 1990 67 : 1355 64.
-
(1990)
Circ Res
, vol.67
, pp. 1355-64
-
-
Brilla, C.G.1
Pick, R.2
Tan, L.B.3
Janicki, J.S.4
Weber, K.T.5
-
14
-
-
85047680324
-
Myocardial fibrosis: Functional significance and regulatory factors
-
Weber KT, Brilla CG, Janicki JS. Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res 1993 27 : 341 8.
-
(1993)
Cardiovasc Res
, vol.27
, pp. 341-8
-
-
Weber, K.T.1
Brilla, C.G.2
Janicki, J.S.3
-
15
-
-
0029097648
-
Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction
-
Hanatani A, Yoshiyama M, Kim S, Omura T, Toda I, Akioka K, Teragaki M, Takeuchi K, Iwao H, Takeda T. Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction. J Mol Cell Cardiol 1995 27 : 1905 14.
-
(1995)
J Mol Cell Cardiol
, vol.27
, pp. 1905-14
-
-
Hanatani, A.1
Yoshiyama, M.2
Kim, S.3
Omura, T.4
Toda, I.5
Akioka, K.6
Teragaki, M.7
Takeuchi, K.8
Iwao, H.9
Takeda, T.10
-
16
-
-
0002807288
-
Cardiac anatomy and pathologic correlates of atrial fibrillation
-
In: edn, eds. Falk, R.H., Podrid, P.J. Philadelphia, PA: Lippincott-Raven
-
Lie JT, Falk RH, James TN. Cardiac anatomy and pathologic correlates of atrial fibrillation. In : Atrial Fibrillation: Mechanisms and Management, 2nd edn, eds Falk RH, Podrid PJ. Philadelphia, PA : Lippincott-Raven, 1997 23 52.
-
(1997)
Atrial Fibrillation: Mechanisms and Management, 2nd
, pp. 23-52
-
-
Lie, J.T.1
Falk, R.H.2
James, T.N.3
-
17
-
-
0030763103
-
Histological substrate of atrial biopsies in patients with lone atrial fibrillation
-
Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997 96 : 1181 4.
-
(1997)
Circulation
, vol.96
, pp. 1181-4
-
-
Frustaci, A.1
Chimenti, C.2
Bellocci, F.3
Morgante, E.4
Russo, M.A.5
Maseri, A.6
-
18
-
-
18744419605
-
Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans
-
Goette A, Arndt M, Rocken C, Spiess A, Staack T, Geller JC, Huth C, Ansorge S, Klein HU, Lendeckel U. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation 2000 101 : 2678 81.
-
(2000)
Circulation
, vol.101
, pp. 2678-81
-
-
Goette, A.1
Arndt, M.2
Rocken, C.3
Spiess, A.4
Staack, T.5
Geller, J.C.6
Huth, C.7
Ansorge, S.8
Klein, H.U.9
Lendeckel, U.10
-
19
-
-
0035923479
-
Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure
-
Li D, Shinagawa K, Pang L, Leung TK, Cardin S, Wang Z, Nattel S. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 2001 104 : 2608 14.
-
(2001)
Circulation
, vol.104
, pp. 2608-14
-
-
Li, D.1
Shinagawa, K.2
Pang, L.3
Leung, T.K.4
Cardin, S.5
Wang, Z.6
Nattel, S.7
-
20
-
-
0028275578
-
Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosterone
-
Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 1994 26 : 809 20.
-
(1994)
J Mol Cell Cardiol
, vol.26
, pp. 809-20
-
-
Brilla, C.G.1
Zhou, G.2
Matsubara, L.3
Weber, K.T.4
-
21
-
-
0027182438
-
Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocyte and hyperplasia of cardiac fibroblasts: Critical role of the AT1 receptor subtype
-
Sadoshima J, Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocyte and hyperplasia of cardiac fibroblasts: critical role of the AT1 receptor subtype. Circ Res 1993 73 : 413 23.
-
(1993)
Circ Res
, vol.73
, pp. 413-23
-
-
Sadoshima, J.1
Izumo, S.2
-
22
-
-
33744960530
-
Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition
-
Okazaki H, Minamino T, Tsukamoto O, Kim J, Okada K, Myoishi M, Wakeno M, Takashima S, Mochizuki N, Kitakaze M. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition. Hypertens Res 2006 29 : 277 82.
-
(2006)
Hypertens Res
, vol.29
, pp. 277-82
-
-
Okazaki, H.1
Minamino, T.2
Tsukamoto, O.3
Kim, J.4
Okada, K.5
Myoishi, M.6
Wakeno, M.7
Takashima, S.8
Mochizuki, N.9
Kitakaze, M.10
-
23
-
-
0242636836
-
Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease
-
Boldt A, Wetzel U, Weigl J, Garbade J, Lauschke J, Hindricks G, Kottkamp H, Gummert JF, Dhein S. Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease. J Am Coll Cardiol 2003 42 : 1785 92.
-
(2003)
J Am Coll Cardiol
, vol.42
, pp. 1785-92
-
-
Boldt, A.1
Wetzel, U.2
Weigl, J.3
Garbade, J.4
Lauschke, J.5
Hindricks, G.6
Kottkamp, H.7
Gummert, J.F.8
Dhein, S.9
-
24
-
-
0034687120
-
Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation
-
Everett THIV, Li H, Mangrum JM, McRury ID, Mitchell MA, Redick JA, Haines DE. Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation. Circulation 2000 102 : 1454 60.
-
(2000)
Circulation
, vol.102
, pp. 1454-60
-
-
Thiv, E.1
Li, H.2
Mangrum, J.M.3
McRury, I.D.4
Mitchell, M.A.5
Redick, J.A.6
Haines, D.E.7
-
25
-
-
0034612362
-
Angiotensin II antagonist prevents electrical remodelling in atrial fibrillation
-
Nakashima H, Kumagai K, Urata H, Gondo N, Ideishi M, Arakawa K. Angiotensin II antagonist prevents electrical remodelling in atrial fibrillation. Circulation 2000 101 : 2612 7.
-
(2000)
Circulation
, vol.101
, pp. 2612-7
-
-
Nakashima, H.1
Kumagai, K.2
Urata, H.3
Gondo, N.4
Ideishi, M.5
Arakawa, K.6
-
26
-
-
33645735529
-
Angiotensin II potentiates the slow component of delayed rectifier K+ current via the AT1 receptor in guinea pig atrial myocytes
-
Zankov DP, Omatsu-Kanbe M, Isono T, Toyoda F, Ding WG, Matsuura H, Horie M. Angiotensin II potentiates the slow component of delayed rectifier K+ current via the AT1 receptor in guinea pig atrial myocytes. Circulation 2006 113 : 1278 86.
-
(2006)
Circulation
, vol.113
, pp. 1278-86
-
-
Zankov, D.P.1
Omatsu-Kanbe, M.2
Isono, T.3
Toyoda, F.4
Ding, W.G.5
Matsuura, H.6
Horie, M.7
-
27
-
-
11144355187
-
Renin-angiotensin system gene polymorphisms and atrial fibrillation
-
Tsai CT, Lai LP, Lin JL, Chiang FT, Hwang JJ, Ritchie MD, Moore JH, Hsu KL, Tseng CD, Liau CS, Tseng YZ. Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation 2004 109 : 1640 6.
-
(2004)
Circulation
, vol.109
, pp. 1640-6
-
-
Tsai, C.T.1
Lai, L.P.2
Lin, J.L.3
Chiang, F.T.4
Hwang, J.J.5
Ritchie, M.D.6
Moore, J.H.7
Hsu, K.L.8
Tseng, C.D.9
Liau, C.S.10
Tseng, Y.Z.11
-
28
-
-
0346034542
-
Angiotensin-converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation
-
Pt 2
-
Gensini F, Padeletti L, Fatini C, Sticchi E, Gensini GF, Michelucci A. Angiotensin-converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation. Pacing Clin Electrophysiol 2003 26 (1 Pt 2 295 8.
-
(2003)
Pacing Clin Electrophysiol
, vol.26
, Issue.1
, pp. 295-8
-
-
Gensini, F.1
Padeletti, L.2
Fatini, C.3
Sticchi, E.4
Gensini, G.F.5
Michelucci, A.6
-
29
-
-
0036247120
-
Relation between angiotensin converting enzyme II genotype and atrial fibrillation in Japanese patients with hypertrophic cardiomyopathy
-
Ogimoto A, Hamada M, Nakura J, Miki T, Hiwada K. Relation between angiotensin converting enzyme II genotype and atrial fibrillation in Japanese patients with hypertrophic cardiomyopathy. J Hum Genet 2002 47 : 184 9.
-
(2002)
J Hum Genet
, vol.47
, pp. 184-9
-
-
Ogimoto, A.1
Hamada, M.2
Nakura, J.3
Miki, T.4
Hiwada, K.5
-
30
-
-
34249738442
-
ACE I/D polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillation
-
Darbar D, Motsinger A, Ritchie MD, Gainer JV, Roden DM. ACE I/D polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillation. Heart Rhythm 2007 4 : 743 9.
-
(2007)
Heart Rhythm
, vol.4
, pp. 743-9
-
-
Darbar, D.1
Motsinger, A.2
Ritchie, M.D.3
Gainer, J.V.4
Roden, D.M.5
-
31
-
-
0031686381
-
Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials
-
Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. J Am Coll Cardiol 1998 32 : 695 703.
-
(1998)
J Am Coll Cardiol
, vol.32
, pp. 695-703
-
-
Dries, D.L.1
Exner, D.V.2
Gersh, B.J.3
Domanski, M.J.4
Waclawiw, M.A.5
Stevenson, L.W.6
-
32
-
-
0038649984
-
Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: Insight from the Studies of Left Ventricular Dysfunction (SOLVD) Trials
-
Vermes E, Tardif JC, Bourassa MG, Racine N, Levesque S, White M, Guerra PG, Ducharme A. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies of Left Ventricular Dysfunction (SOLVD) Trials. Circulation 2003 107 : 2926 31.
-
(2003)
Circulation
, vol.107
, pp. 2926-31
-
-
Vermes, E.1
Tardif, J.C.2
Bourassa, M.G.3
Racine, N.4
Levesque, S.5
White, M.6
Guerra, P.G.7
Ducharme, A.8
-
33
-
-
0033609470
-
Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction
-
Pedersen OD, Bagger H, Kober L, Torp-Pedersen C. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 1999 100 : 376 38.
-
(1999)
Circulation
, vol.100
, pp. 376-38
-
-
Pedersen, O.D.1
Bagger, H.2
Kober, L.3
Torp-Pedersen, C.4
-
34
-
-
0033034404
-
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPP) randomised trial
-
Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, Luomanmäki K, Dahlöf B, de Faire U, Mörlin C, Karlberg BE, Wester PO, Björck JE. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPP) randomised trial. Lancet 1999 20 : 611 16.
-
(1999)
Lancet
, vol.20
, pp. 611-16
-
-
Hansson, L.1
Lindholm, L.H.2
Niskanen, L.3
Lanke, J.4
Hedner, T.5
Niklason, A.6
Luomanmäki, K.7
Dahlöf, B.8
De Faire, U.9
Mörlin, C.10
Karlberg, B.E.11
Wester, P.O.12
Björck, J.E.13
-
35
-
-
0033589756
-
Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
-
Hansson L, Lindholm LH, Ekbom T, Dahlöf B, Lanke J, Scherstén B, Wester PO, Hedner T, de Faire U. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 1999 20 : 1751 6.
-
(1999)
Lancet
, vol.20
, pp. 1751-6
-
-
Hansson, L.1
Lindholm, L.H.2
Ekbom, T.3
Dahlöf, B.4
Lanke, J.5
Scherstén, B.6
Wester, P.O.7
Hedner, T.8
De Faire, U.9
-
36
-
-
20044369896
-
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention for End Point Reduction in Hypertension (LIFE) study
-
Wachtell K, Lehto M, Gerdts E, Olsen MH, Hornestam B, Dahlöf B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Devereux RB. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention for End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol 2005 45 : 712 9.
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 712-9
-
-
Wachtell, K.1
Lehto, M.2
Gerdts, E.3
Olsen, M.H.4
Hornestam, B.5
Dahlöf, B.6
Ibsen, H.7
Julius, S.8
Kjeldsen, S.E.9
Lindholm, L.H.10
Nieminen, M.S.11
Devereux, R.B.12
-
37
-
-
20044388522
-
Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention for End Point Reduction in Hypertension (LIFE) study
-
Wachtell K, Hornestam B, Lehto M, Slotwiner DJ, Gerdts E, Olsen MH, Aurup P, Dahlöf B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Rokkedal J, Devereux RB. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: the Losartan Intervention for End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol 2005 45 : 705 12.
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 705-12
-
-
Wachtell, K.1
Hornestam, B.2
Lehto, M.3
Slotwiner, D.J.4
Gerdts, E.5
Olsen, M.H.6
Aurup, P.7
Dahlöf, B.8
Ibsen, H.9
Julius, S.10
Kjeldsen, S.E.11
Lindholm, L.H.12
Nieminen, M.S.13
Rokkedal, J.14
Devereux, R.B.15
-
38
-
-
17844369714
-
Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)
-
Val-HeFT Investigators
-
Maggioni AP, Latini R, Peter E, Carson PE, Singh SN, Barlera S, Glazer R, Masson S, Cerè E, Tognoni G, Cohn JN Val-HeFT Investigators. Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT). Am Heart J 2005 149 : 548 5.
-
(2005)
Am Heart J
, vol.149
, pp. 548-5
-
-
Maggioni, A.P.1
Latini, R.2
Peter, E.3
Carson, P.E.4
Singh, S.N.5
Barlera, S.6
Glazer, R.7
Masson, S.8
Cerè, E.9
Tognoni, G.10
Cohn, J.N.11
-
39
-
-
33747459636
-
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program
-
CHARM Investigators
-
Ducharme A, Swedber K, Pfeffer MA, Cohen-Solal A, Granger CB, Maggioni AP, Michelson EL, McMurray JJ, Olsson L, Rouleau JL, Young JB, Olofsson B, Puu M, Yusuf S CHARM Investigators. Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program. Am Heart J 2006 152 : 86 92.
-
(2006)
Am Heart J
, vol.152
, pp. 86-92
-
-
Ducharme, A.1
Swedber, K.2
Pfeffer, M.A.3
Cohen-Solal, A.4
Granger, C.B.5
Maggioni, A.P.6
Michelson, E.L.7
McMurray, J.J.8
Olsson, L.9
Rouleau, J.L.10
Young, J.B.11
Olofsson, B.12
Puu, M.13
Yusuf, S.14
-
40
-
-
0037118662
-
Use of irbesartn to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: A prospective and randomized study
-
Madrid HA, Bueno MG, Rebollo JM, Marín I, Peña G, Bernal E, Rodriguez A, Cano L, Cano JM, Cabeza P, Moro C. Use of irbesartn to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study. Circulation 2002 106 : 331 8.
-
(2002)
Circulation
, vol.106
, pp. 331-8
-
-
Madrid, H.A.1
Bueno, M.G.2
Rebollo, J.M.3
Marín, I.4
Peña, G.5
Bernal, E.6
Rodriguez, A.7
Cano, L.8
Cano, J.M.9
Cabeza, P.10
Moro, C.11
-
41
-
-
33748806572
-
Pre-treatment with irbesartan attenuates left atrial stunning after electrical cardioversion of atrial fibrillation
-
Dagres N, Karatasakis G, Panou F, Athanassopoulos G, Maounis T, Tsougos E, Kourea K, Malakos I, Kremastinos DT, Cokkinos DV. Pre-treatment with irbesartan attenuates left atrial stunning after electrical cardioversion of atrial fibrillation. Eur Heart J 2006 27 : 2062 8.
-
(2006)
Eur Heart J
, vol.27
, pp. 2062-8
-
-
Dagres, N.1
Karatasakis, G.2
Panou, F.3
Athanassopoulos, G.4
Maounis, T.5
Tsougos, E.6
Kourea, K.7
Malakos, I.8
Kremastinos, D.T.9
Cokkinos, D.V.10
-
42
-
-
33748087086
-
Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation
-
Yin Y, Dalal D, Liu Z, Wu J, Liu D, Lan X, Dai Y, Su L, Ling Z, She Q, Luo K, Woo K, Dong J. Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation. Eur Heart J 2006 27 : 1841 7.
-
(2006)
Eur Heart J
, vol.27
, pp. 1841-7
-
-
Yin, Y.1
Dalal, D.2
Liu, Z.3
Wu, J.4
Liu, D.5
Lan, X.6
Dai, Y.7
Su, L.8
Ling, Z.9
She, Q.10
Luo, K.11
Woo, K.12
Dong, J.13
-
43
-
-
6444219596
-
Prevention of recurrences in patients with lone atrial fibrillation. the dose-dependent effect of Angiotensin II receptor blockers
-
Madrid HA, Marin IM, Cervantes CE, Morell EB, Estévez JE, Moreno G, Parajón JR, Peng J, Limón L, Nannini S, Moro C. Prevention of recurrences in patients with lone atrial fibrillation. The dose-dependent effect of Angiotensin II receptor blockers. J Renin Angiotensin Aldosterone Syst 2004 5 : 114 20.
-
(2004)
J Renin Angiotensin Aldosterone Syst
, vol.5
, pp. 114-20
-
-
Madrid, H.A.1
Marin, I.M.2
Cervantes, C.E.3
Morell, E.B.4
Estévez, J.E.5
Moreno, G.6
Parajón, J.R.7
Peng, J.8
Limón, L.9
Nannini, S.10
Moro, C.11
-
44
-
-
10744221998
-
Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-lasting persistent atrial fibrillation: Results of a prospective and controlled study
-
Ueng KC, Tsai TP, Yu WC, Tsai CF, Lin MC, Chan KC, Chen CY, Wu DJ, Lin CS, Chen SA. Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-lasting persistent atrial fibrillation: results of a prospective and controlled study. Eur Heart J 2003 24 : 2090 8.
-
(2003)
Eur Heart J
, vol.24
, pp. 2090-8
-
-
Ueng, K.C.1
Tsai, T.P.2
Yu, W.C.3
Tsai, C.F.4
Lin, M.C.5
Chan, K.C.6
Chen, C.Y.7
Wu, D.J.8
Lin, C.S.9
Chen, S.A.10
-
45
-
-
20344396863
-
Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
-
Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfinkle M, Yusuf S, Connolly SJ. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. J Am Coll Cardiol 2005 45 : 1832 9.
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 1832-9
-
-
Healey, J.S.1
Baranchuk, A.2
Crystal, E.3
Morillo, C.A.4
Garfinkle, M.5
Yusuf, S.6
Connolly, S.J.7
-
46
-
-
29744454333
-
The impact of suppressing the renin-angiotensin system on atrial fibrillation
-
Kalus JS, Coleman CI, White CM. The impact of suppressing the renin-angiotensin system on atrial fibrillation. J Clin Pharmacol 2006 46 : 21 8.
-
(2006)
J Clin Pharmacol
, vol.46
, pp. 21-8
-
-
Kalus, J.S.1
Coleman, C.I.2
White, C.M.3
-
47
-
-
33746257148
-
Meta-analysis: Inhibition of renin-angiotensin system prevents new-onset atrial fibrillation
-
Anand K, Mooss AN, Hee TT, Mohiuddin SM. Meta-analysis: inhibition of renin-angiotensin system prevents new-onset atrial fibrillation. Am Heart J 2006 152 : 217 22.
-
(2006)
Am Heart J
, vol.152
, pp. 217-22
-
-
Anand, K.1
Mooss, A.N.2
Hee, T.T.3
Mohiuddin, S.M.4
-
48
-
-
34447540172
-
Inefficiency of renin-angiotensin inhibitors in preventing atrial fibrillation in patients with a normal heart
-
Fazio G, Pizzuto C, Sutera L, Guttilla D, Di Gesaro G, Cascio C, Novo G, Assennato P, Novo S. Inefficiency of renin-angiotensin inhibitors in preventing atrial fibrillation in patients with a normal heart. Minerva Cardioangiol 2007 55 : 311 15.
-
(2007)
Minerva Cardioangiol
, vol.55
, pp. 311-15
-
-
Fazio, G.1
Pizzuto, C.2
Sutera, L.3
Guttilla, D.4
Di Gesaro, G.5
Cascio, C.6
Novo, G.7
Assennato, P.8
Novo, S.9
-
49
-
-
3142740224
-
Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients
-
ONTARGET/TRASCEND Investigators
-
Teo K, Yusuf S, Seight P, Anderson C, Mookadam F, Ramos B, Hilbrich L, Pogue J, Schumacher H ONTARGET/TRASCEND Investigators. Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials. Am Heart J 2004 148 : 52 61.
-
(2004)
Am Heart J
, vol.148
, pp. 52-61
-
-
Teo, K.1
Yusuf, S.2
Seight, P.3
Anderson, C.4
Mookadam, F.5
Ramos, B.6
Hilbrich, L.7
Pogue, J.8
Schumacher, H.9
-
50
-
-
42049107348
-
The ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events
-
ONTARGET Investigators
-
ONTARGET Investigators, Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C. The ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008 358 : 1547 59.
-
(2008)
N Engl J Med
, vol.358
, pp. 1547-59
-
-
Yusuf, S.1
Teo, K.K.2
Pogue, J.3
Dyal, L.4
Copland, I.5
Schumacher, H.6
Dagenais, G.7
Sleight, P.8
Anderson, C.9
-
51
-
-
33746206423
-
Rationale and design of ACTIVE: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events
-
Connolly S, Yusuf S, Budaj A, Camm J, Chrolavicius S, Commerford PJ, Flather M, Fox KA, Hart R, Hohnloser S, Joyner C, Pfeffer M, Anand I, Arthur H, Avezum A, Bethala-Sithya M, Blumenthal M, Ceremuzynski L, De Caterina R, Diaz R, Flaker G, Frangin G, Franzosi MG, Gaudin C, Golitsyn S, Goldhaber S, Granger C, Halon D, Hermosillo A, Hunt D, Jansky P, Karatzas N, Keltai M, Lanas F, Lau CP, Le Heuzey JY, Lewis BS, Morais J, Morillo C, Oto A, Paolasso E, Peters RJ, Pfisterer M, Piegas L, Pipillis T, Proste C, Sitkei E, Swedberg K, Synhorst D, Talajic M, Trégou V, Valentin V, van Mieghem W, Weintraub W, Varigos J. Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events. Am Heart J 2006 151 : 1187 93.
-
(2006)
Am Heart J
, vol.151
, pp. 1187-93
-
-
Connolly, S.1
Yusuf, S.2
Budaj, A.3
Camm, J.4
Chrolavicius, S.5
Commerford, P.J.6
Flather, M.7
Fox, K.A.8
Hart, R.9
Hohnloser, S.10
Joyner, C.11
Pfeffer, M.12
Anand, I.13
Arthur, H.14
Avezum, A.15
Bethala-Sithya, M.16
Blumenthal, M.17
Ceremuzynski, L.18
De Caterina, R.19
Diaz, R.20
Flaker, G.21
Frangin, G.22
Franzosi, M.G.23
Gaudin, C.24
Golitsyn, S.25
Goldhaber, S.26
Granger, C.27
Halon, D.28
Hermosillo, A.29
Hunt, D.30
Jansky, P.31
Karatzas, N.32
Keltai, M.33
Lanas, F.34
Lau, C.P.35
Le Heuzey, J.Y.36
Lewis, B.S.37
Morais, J.38
Morillo, C.39
Oto, A.40
Paolasso, E.41
Peters, R.J.42
Pfisterer, M.43
Piegas, L.44
Pipillis, T.45
Proste, C.46
Sitkei, E.47
Swedberg, K.48
Synhorst, D.49
Talajic, M.50
Trégou, V.51
Valentin, V.52
Van Mieghem, W.53
Weintraub, W.54
Varigos, J.55
more..
-
52
-
-
33744492323
-
Rationale and design of the GISSI-Atrial Fibrillation Trial: A randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence
-
GISSI-AF Investigators
-
Disertori M, Latini R, Maggioni AP, Delise P, Di Pasquale G, Franzosi MG, Staszewsky L, Tognoni G GISSI-AF Investigators. Rationale and design of the GISSI-Atrial Fibrillation Trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence. J Cardiovasc Med (Hagerstown) 2006 7 : 29 38.
-
(2006)
J Cardiovasc Med (Hagerstown)
, vol.7
, pp. 29-38
-
-
Disertori, M.1
Latini, R.2
Maggioni, A.P.3
Delise, P.4
Di Pasquale, G.5
Franzosi, M.G.6
Staszewsky, L.7
Tognoni, G.8
|